Company intelligence / Profile preview

Awakn Life Sciences

London, United Kingdomawaknlifesciences.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Awakn has demonstrated clinical efficacy with its ketamine-assisted therapy program for Severe Alcohol Use Disorder. The company’s lead program was licensed from the University of Exeter following positive Phase II results. A pivotal Phase III trial was planned to start in H2 2023. Preclinical work continues on novel compounds targeting trauma-related mental health conditions such as PTSD.

Therapeutic areas: Psychiatry
Modalities: Psychedelic therapeutics (e.g., ketamine-based therapies)Serotonin, dopamine, and noradrenaline modulatorsMedication-assisted treatments (MATs)
Industry: Biotech

Drug pipeline

3 assets

AW21003

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborates with pharma companies, state bodies, and research institutes; specific partners not named in public sources.Licensed key clinical program from University of Exeter.

Beyond the preview

Go deeper on Awakn Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Awakn Life Sciences.

Explore the full profile